Registration Begins

Breakfast

Welcoming Remarks
Yanhong Lin and Feng Han, Managing Partners, CTIC Capital

Keynote: From Nanotechnology to mRNA Vaccines: How Overcoming Skepticism and Barriers Led to New Cancer Treatments and Ways to Tackle A Global Health Challenge (including Q&A)
Robert Langer, Institute Professor, MIT

Keynote: New Financing and Payment Models for Gene and Cell Therapies (including Q&A)

Andrew Lo, The Charles E. and Susan T. Harris Professor of Finance and the Laboratory for Financial Engineering Director at the MIT Sloan School of Management

Panel Discussion: Global Healthcare Investment: Navigating Challenges and Market Dynamics
Panel Lead, Helen Chen, Global Sector Co-Head, Healthcare and Life Science, LEK
Doug Fisher, Partner, Revelation Partners
James Huang, Founding Managing Partner, Panacea Venture
Karen Liu, Founding Partner, 3E Bioventures Capital
Chong Xu, Partner, F-Prime Capital
James Zhao, Founding Partner, LYFE Capital

Luncheon/Networking

Panel Discussion: Early Innovation Horizons – Opportunities Beyond Boundaries
Panel Lead, KT Moortgat, Biotech Advisor; Former West Coast Head, AbbVie Ventures
Kan Chen, Partner, Qiming Venture Partners
Stacy Feld, Regional Head, Johnson & Johnson Innovation
John Lepore, CEO-Partner, Flagship Pioneering and CEO of ProFound Therapeutics, Former Senior Vice President, Head of Research, GSK
Ricky Sun, Partner, Bain Capital Life Science

Panel Discussion: Early Innovation Horizons in Medtech – Opportunities Beyond Boundaries
Panel Lead, Feng Han, Managing Partner, CTIC Capital
Victor Shi, Managing Partner, Serica Partners
Hongjie Hu, Managing Partner, Healthcare at Cathay Capital
Licen (Lisa) Xu, CCO of FlashDx, Former Vice President of Roche Sequencing Systems

Company Presentations
1. HanchorBio Inc.
2. WD Pharma
3. T-Maximum BioTech
4. ONL Terapeutics
5. Novadip
6. Myrobalan Therapeutics
7. Mekanstic Therapeutics Inc.
8. Exuma Biotech
9. Aureka Biotechnologies

Break

Panel Discussion: The Next Leap in Medicine: AI’s Emerging Role in Drug Discovery and Clinical Applications
Panel Lead, Zeenat Patrawala, Chief Business Officer, VantAI
Alex Gasner, Executive Vice President, Roivant
Matthew Lungren, Chief Medical Information Officer, Microsoft
Becky Pferdehirt, Investing Partner, a16z Bio + Health
Jason Spring, Co-Founder, CEO, Endpoint Health
Lu Zhang, Founder and Managing Partner, Fusion Fund

Panel Discussion: Innovation Insights: Bio Pharma’s Top Picks for Future Success: Quest for Cutting Edge Technologies

Panel Lead: Wendy Pan, Partner, Goodwin Procter LLP
Martin Crook, Vice President, Corporate Development Assessments at Bristol Myers Squibb

Niels Emmerich, Vice President, Global S&E and Alliances, Abbvie
Mark Rowen, Vice President, Corporate Development, Denali Therapeutics
Liangsu Wang, Vice President, J&J Innovation – CVD, Metabolism, Retina, and PH

Shanshan Xu, Vice President, External Innovations at BioNTech SE

Closing Remarks
Niels Emmerich, Vice President, Global S&E and Alliances, Abbvie